Lenalidomid Devatis 5 mg, Hartkapseln - 21 Swissmedic Key 68518009 Registration Holder Devatis AG Name Lenalidomid Devatis 5 mg, Hartkapseln Date of registration 12.01.2022 Original/Generic Generic Introduction of Sequence 12.01.2022 ATC-Classification Lenalidomide (L04AX04) Revision date WHO WHO-DDD Valid until 11.01.2027 Index Therapeuticus (BSV) 07.16.10. Show package size 21 Index Therapeuticus (Swissmedic) 07.16.40. Description Swissmedic categorie. A SL Eintrag Yes Indication Information for professionals IP Consumer information Ex-factory-Price 707.76 Limitation Yes Limitation text
Deductible 10 % Consumer price 786.15 Feedback FB Daily cost GTIN 7680685180094 Medication Code Synthetika Pharmacode Disponibility
Composition lenalidomidum 5.0 mg, lactosum 40.0 mg, cellulosum microcristallinum, carmellosum natricum conexum corresp. natrium 0.408 mg, magnesii stearas, Kapselhülle: gelatina, titanii dioxidum, Drucktinte: lacca, propylenglycolum, ammoniae solutio 30 per centum, E 172 (nigrum), kalii hydroxidum, pro capsula. Packungsbestandteile Galenic Form Capsules Active Agent Dose Lenalidomidum 5 mg
BAG: Active Agent Dose Lenalidomidum 5 mg
Inactive agents Dose additional_information (Nigrum) Ammoniae Solutio 30 Carmellosum Natricum Conexum Cellulosum Microcristallinum E 172 color. Gelatina Kapselhülle Kalii Hydroxidum Lacca Drucktinte Lactosum 40 mg Magnesii Stearas Per Centum Pro Capsula Propylenglycol Titanium Dioxide
Source Data was imported : 12.01.2023
Swissmedic Registration :
Sequence :
Product name :
Registration owner: :
Product group :
Index Therapeuticus (BSV) :
Medication Code :
Date of registration :
Valid until :
Package number :
Show package size :
Commercial Form/Unit :
Swissmedic categorie. :
Active Agents :
Composition :
